Summit K. Chanda

Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program

United States

SCHOLARLY PAPERS

4

DOWNLOADS

115

SSRN CITATIONS

7

CROSSREF CITATIONS

0

Scholarly Papers (4)

1.

MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells

Number of pages: 40 Posted: 03 Sep 2020
Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Kyoto University - Department of Drug Discovery for Lung Diseases, Kyoto University - Department of Drug Discovery for Lung Diseases, National Institute of Infectious Diseases - Department of Veterinary Science, Kyoto University - Department of Drug Discovery for Lung Diseases, QBI Coronavirus Research Group (QCRG), Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford-Burnham Medical Research Institute - Functional Genomics Core, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Northwestern University - Divisions of Infectious Diseases, QBI Coronavirus Research Group (QCRG) and Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program
Downloads 43 (750,413)
Citation 4

Abstract:

Loading...

Innate immunity, SARS-CoV-2, COVID-19, innate immune signaling, pattern recognition receptors

2.

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

Number of pages: 53 Posted: 17 Aug 2020
University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine, University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine, University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine, University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine, University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine, TEGA Therapeutics, TEGA Therapeutics, Pennsylvania State University - Department of Biochemistry and Molecular Biology, Pennsylvania State University - Department of Biochemistry and Molecular Biology, University of Copenhagen - Copenhagen Center for Glycomics, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine, University of California, San Diego (UCSD) - Department of Chemistry and Biochemistry, University of California, San Diego (UCSD) - Department of Medicine, University of California, San Diego (UCSD) - Department of Chemistry and Biochemistry, Ragon Institute of MGH, MIT and Harvard, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, University of California, San Diego (UCSD) - Department of Bioengineering, University of California, San Diego (UCSD) - Department of Bioengineering, University of California, San Diego (UCSD) - Department of Medicine, University of California, San Diego (UCSD) - Department of Pediatrics, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Ragon Institute of MGH, MIT and Harvard, University of California, San Diego (UCSD) - Department of Chemistry and Biochemistry, Pennsylvania State University - Department of Biochemistry and Molecular Biology, University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of California, San Diego (UCSD) - Department of Medicine and University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine
Downloads 31 (841,023)
Citation 6

Abstract:

Loading...

COVID-19, SARS-CoV-2, Coronavirus, Spike proteins, Heparin,Heparan Sulfate,Pseudotype virus

3.

Synthetic Lethality-Based Prediction of Anti-SARS-CoV-2 Targets

Number of pages: 29 Posted: 20 Oct 2021
Government of the United States of America - Cancer Data Science Laboratory, Government of the United States of America - Cancer Data Science Laboratory, Government of the United States of America - Cancer Data Science Laboratory, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Government of the United States of America - Cancer Data Science Laboratory, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Government of the United States of America - Cancer Data Science Laboratory, Government of the United States of America - Cancer Data Science Laboratory, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program and University of Maryland - Center for Bioinformatics and Computational Biology
Downloads 21 (930,904)

Abstract:

Loading...

SARS-CoV-2, Covid-19, Synthetic lethality, siRNA screen, CRISPR-Cas9 screen, covid19 therapeutic target

4.

Functional Landscape of SARS-CoV-2 Cellular Restriction

Number of pages: 59 Posted: 13 Oct 2020
Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, University of California, San Diego (UCSD) - Department of Medicine, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, University of California, San Diego (UCSD) - Department of Medicine, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, University of California, San Diego (UCSD) - Department of Medicine, University of California, San Diego (UCSD) - Drug Design Data Resource, University of California, San Diego (UCSD) - Center for Computational Biology and Bioinformatics, University of California, San Diego (UCSD) - Department of Medicine, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, University of California, San Diego (UCSD) - Department of Dermatology, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, University of California, San Diego (UCSD) - Department of Medicine, QBI Coronavirus Research Group (QCRG), Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Icahn School of Medicine at Mount Sinai - Department of Microbiology, Icahn School of Medicine - Department of Microbiology, University of California, San Diego (UCSD) - Department of Medicine, University of California, San Diego (UCSD) - Department of Medicine, University of Maryland, Baltimore County (UMBC) - Department of Microbiology and Immunology, QBI Coronavirus Research Group (QCRG), University of California, San Diego (UCSD) - Department of Medicine, Northwestern University - Division of Infectious Diseases, University of California, San Diego (UCSD) - Department of Medicine and Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program
Downloads 20 (940,839)
Citation 3

Abstract:

Loading...